Related news from
Fri, 28 Nov 2025 12:08:00 +0000	CVS Health Delivers MBR Improvement: Is More Progress in the Cards? CVS posts a sharper MBR as PDR impacts ease and government business strengthens while maintaining a cautious full-year outlook.
Thu, 27 Nov 2025 22:10:36 +0000	How Investors Are Reacting To Cencora (COR) Expanding Global Reach With Alliance Healthcare Acquisition On November 25, 2025, Cencora Inc filed its annual 10-K report, detailing substantial financial growth and highlighting its acquisition of Alliance Healthcare to strengthen its global pharmaceutical distribution capabilities. The report also underscored Cencora's expanding opportunities in international markets and specialty pharmaceuticals, while noting increased operating expenses and ongoing litigation risks as important challenges. We'll now explore how Cencora's expanded international...
Thu, 27 Nov 2025 20:08:59 +0000	Should You Take Another Look at Cencora After a 64% Rally in 2025? Curious if Cencora stock still offers good value or if recent gains have pushed it out of reach? You are not alone in wondering whether now is the right time to take a closer look. Shares have been on the move, rising 2.2% in the past week and 64.0% year-to-date, building on an impressive 277.7% gain over the last five years. Recent headlines have highlighted Cencora’s expansive strategies, including major partnerships and sector-leading initiatives. These developments are fueling fresh...
Thu, 27 Nov 2025 15:13:00 +0000	A Fresh Look at Cencora (COR) Valuation Following Its Recent Share Price Momentum Cencora (COR) has shown a steady performance in recent weeks, catching the attention of investors who are watching for shifts in the healthcare distribution space. The stock’s trajectory offers an interesting lens into ongoing sector trends. See our latest analysis for Cencora. Cencora’s latest share price of $368.53 caps off an impressive run, with a 9.7% 1-month share price return and momentum continuing to build after recent sector tailwinds. Over the last year, shareholders enjoyed a...
Wed, 26 Nov 2025 14:09:00 +0000	GEHC Stock Gains Post Latest Launch to Optimize Radiology Workflows GE HealthCare unveils Genesis Radiology Workspace, aiming to streamline imaging workflows and boost diagnostic precision.
Mon, 24 Nov 2025 14:15:03 +0000	Cencora, Inc. (COR) Hits Fresh High: Is There Still Room to Run? Cencora (COR) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
Fri, 21 Nov 2025 14:40:02 +0000	Are Medical Stocks Lagging Cencora, Inc. (COR) This Year? Here is how Cencora (COR) and Boston Scientific (BSX) have performed compared to their sector so far this year.
Tue, 18 Nov 2025 14:15:04 +0000	Progyny, Inc. (PGNY) Hit a 52 Week High, Can the Run Continue? Progyny (PGNY) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
Mon, 17 Nov 2025 13:40:00 +0000	Take the Zacks Approach to Beat the Markets: Macy's, United Natural Foods & Monster Beverage in Focus Macy's climbs after a Zacks upgrade as multiple portfolios showcase strong gains across UNFI, Monster Beverage and other standout stocks.
Fri, 14 Nov 2025 04:41:48 +0000	1 Healthcare Stock to Own for Decades and 2 We Avoid Healthcare companies are pushing the status quo by innovating in areas like drug development and digital health. But speed bumps such as inventory destockings have persisted in the wake of COVID-19, limiting growth. This has capped returns as the industry’s six-month gain of 11.6% has lagged the S&P 500’s 16.3% climb.
Wed, 12 Nov 2025 11:06:52 +0000	Cencora (COR): Assessing Valuation After Sustained Share Price Growth Shares of Cencora (COR) have been catching the attention of investors recently, with the stock showing marked movement over the past month and more than doubling in value across the past three years. Recent trading reflects a generally positive trajectory and has prompted closer inspection of what might be driving this performance. See our latest analysis for Cencora. Cencora’s share price momentum has steadily increased, notching a 14.8% gain over the past month and climbing 62.45%...
Wed, 12 Nov 2025 10:33:55 +0000	Why Cencora's (NYSE:COR) Earnings Are Better Than They Seem Investors signalled that they were pleased with Cencora, Inc.'s ( NYSE:COR ) most recent earnings report. Looking...
Wed, 12 Nov 2025 05:36:31 +0000	The 5 Most Interesting Analyst Questions From Cencora’s Q3 Earnings Call Cencora’s third quarter saw a positive market response, as the company delivered revenue and non-GAAP earnings that exceeded Wall Street expectations. Management pointed to strong growth in its U.S. Healthcare Solutions segment and the contribution of specialty pharmaceuticals as key drivers. CEO Robert Mauch emphasized that investments in areas like specialty distribution and recent acquisitions, such as Retina Consultants of America, enhanced the company’s value to both pharmaceutical manufact
Tue, 11 Nov 2025 09:51:02 +0000	Cencora Stock: Is Wall Street Bullish or Bearish? Pharma distributor Cencora has continued to outpace the broader market over the past year, and analysts remain strongly bullish on the stock’s prospects.
Thu, 06 Nov 2025 21:45:40 +0000	Cencora makes $1 billion investment in pharma supply chains Cencora is betting on the future of pharmaceutical logistics, announcing a $1 billion investment through 2030 to expand and modernize its U.S. distribution infrastructure. This move is not just network growth, but a shift aimed at supporting the rising demand of prescription medications and strengthening the reliability of the supply chain that delivers them. The […] The post Cencora makes $1 billion investment in pharma supply chains appeared first on FreightWaves.
Thu, 06 Nov 2025 11:21:22 +0000	Cencora to invest $1bn in US pharma distribution network The second national distribution centre, which is in Harrison, Ohio, will be operational by spring 2027.
Thu, 06 Nov 2025 08:16:20 +0000	Cencora (COR): $713 Million One-Off Loss Challenges Bull Case on Margin Recovery Cencora (COR) posted a net profit margin of 0.6%, a notch below last year’s 0.7%, while earnings rose 2.2% in the latest period, a significant slowdown from its 48.8% average annual growth rate over the past five years. Looking ahead, analysts expect earnings to increase by 11.04% per year, trailing the broader US market’s 16%, with the top line forecast to grow 6.7% versus the market’s 10.5%. However, the results were overshadowed by a one-off loss of $713.2 million in the trailing 12 months...
Thu, 06 Nov 2025 05:34:31 +0000	COR Q3 Deep Dive: Specialty Expansion and Portfolio Restructuring Drive Strategic Focus Healthcare distributor Cencora (NYSE:COR) reported Q3 CY2025 results topping the market’s revenue expectations, with sales up 5.9% year on year to $83.73 billion. Its non-GAAP profit of $3.84 per share was 1.4% above analysts’ consensus estimates.
Wed, 05 Nov 2025 22:23:12 +0000	McKesson raises annual profit forecast on robust demand for specialty drugs (Reuters) -Drug distributor McKesson raised its fiscal 2026 profit forecast on Wednesday, betting on strong growth in its oncology and specialty drug distribution businesses.
Wed, 05 Nov 2025 21:00:34 +0000	Cencora Inc (COR) Q4 2025 Earnings Call Highlights: Strategic Investments Propel Growth Amid ... Cencora Inc (COR) reports robust growth in adjusted income and EPS, while navigating goodwill impairments and strategic realignments.

If you are already a Value Forum member but are not logged on, click here to log on. If you are a guest, thank you for visiting ValueForum -- click here for information about guest access or click here to join -- a Trial Pass can be purchased for $6.99 to help you decide if you want to commit to longer term membership. Did you know there are customized portals into VF like REITs.ValueForum.com and also My ValueForum which lets you customize your VF experience to the posters and topics that most interest you!